Skip to main content

Table 2 Availability of anti-malarial drugs in Burundi (70 outlets), by public and private sector

From: Anti-malarial market and policy surveys in sub-Saharan Africa

  Number of anti-malarial drugs in outlets surveyed (n=243) Number of anti-malarial drugs in the public sector (n=132) Number of anti-malarial drugs in the private sector (n=111)
Amodiaquine (AQ) 1 (0.4%) 0 1 (0.9%)
Artemether+lumefantrine (AR+LUM) 3 (1.2%) 0 3 (2.7%)
Artesunate+amodiaquine (AS+AQ) 61 (25.1%) 46 (34.8%) 15 (13.5%)
Dihydroartemisinin + piperaquine (DHA+PQ) 1 (0.4%) 0 1 (0.9%)
Dihydroartemisinin (DHA) 4 (1.6%) 0 4 (3.6%)
Halofantrine 16 (6.6%) 2 (1.5%) 14 (12.6%)
Quinine injection 54 (22.2%) 29 (22.0%) 25 (22.5%)
Quinine tablets 103 (42.4%) 55 (41.7%) 48 (43.2%)
  1. Data are n (%).